North Korea vs Late-demographic dividend: Immunization, measles
North Korea
99.0%
in 2024
Late-demographic dividend
94.6%
in 2024
North Korea rank
1st
Late-demographic dividend rank
4th
Immunization, measles over time
- North Korea
- Late-demographic dividend
How they compare
North Korea currently reports 99.0% against 94.6% in Late-demographic dividend, a difference of 4.4%.
The two have swapped places 6 times across 45 shared years of data; in 1980 it was North Korea ahead.
North Korea ranks 1st and Late-demographic dividend ranks 4th of 193 countries.
Across the 5 decades both report, North Korea averaged higher in 3 and Late-demographic dividend in 2.
Head to head by decade
| Decade | North Korea | Late-demographic dividend | Difference | Ahead |
|---|---|---|---|---|
| 1980s | 42.4% | 55.7% | 13.3% | Late-demographic dividend |
| 1990s | 74.0% | 86.3% | 12.3% | Late-demographic dividend |
| 2000s | 94.5% | 92.1% | 2.4% | North Korea |
| 2010s | 98.8% | 97.8% | 1.0% | North Korea |
| 2020s | 99.0% | 94.2% | 4.8% | North Korea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, measles, North Korea or Late-demographic dividend?
- North Korea, at 99.0% against 94.6% in Late-demographic dividend as of 2024.
- What is the difference in immunization, measles between North Korea and Late-demographic dividend?
- 4.4%, with North Korea ahead.
- How many years of comparable data are there for North Korea and Late-demographic dividend?
- 45 years are reported by both, from 1980 to 2024.
- How do North Korea and Late-demographic dividend rank globally for immunization, measles?
- North Korea ranks 1st and Late-demographic dividend ranks 4th of 193 countries.
- Where does this data come from?
- World Health Organization (WHO), published as Immunization, measles (% of children ages 12-23 months). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization, measles, measures the percentage of children ages 12-23 months who received the measles vaccination before 12 months or at any time before the survey. A child is considered adequately immunized against measles after receiving one dose of vaccine.